No clinical evidence for CD4+ cell depletion caused by rituximab.
Saville
M Wayne
MW
Benyunes
Mark C
MC
Multani
Pratik S
PS
D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D058846:Antibodies, Monoclonal, Murine-Derived; D015496:CD4-Positive T-Lymphocytes / Q000187:drug effects*; D006801:Humans; D018655:Lymphocyte Count; D000069283:Rituximab
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab